WallStreetZenWallStreetZen

NASDAQ: NMRA
Neumora Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Neumora Therapeutics earnings were -$252.1M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest NMRA earnings report on Jun 30, 2025 announced Q2 2025 earnings of -$52.7M, down 22.4% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, NMRA reported annual earnings of -$243.8M, with 3.3% growth.

NMRA earnings history

Current Revenue
$0.0
Current Earnings
-$252.1M
Current Profit Margin
0%

NMRA Return on Equity

Current Company
-99%
Current Industry
-10.1%
Current Market
30.7%
NMRA's Return on Equity (-99%)... subscribe to Premium to read more.
High Return on Equity Performance

NMRA undefined

Current Company
-87.7%
Current Industry
-0.2%
NMRA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when NMRA announces earnings.

NMRA undefined

Current Company
-124.29%
Current Industry
6.4%

NMRA vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
NMRA-$247.95M-$252.09MN/A-$1.57
NGNE-$80.47M-$84.39MN/A-$4.31
DBVT-$121.87M-$125.13MN/A-$5.15
FULC-$69.70M-$71.11MN/A-$1.14
ALMS-$232.06M-$227.52MN/A-$3.00
View Top Biotech Stocks

Neumora Therapeutics Earnings Reports & History FAQ

What were Neumora Therapeutics's earnings last quarter?

On NMRA's earnings call on Invalid Date, Neumora Therapeutics (NASDAQ: NMRA) reported Q2 2025 earnings per share (EPS) of -$0.33, up 10.81% year over year. Total NMRA earnings for the quarter were -$52.73 million. In the same quarter last year, Neumora Therapeutics's earnings per share (EPS) was -$0.37.

If you're new to stock investing, here's how to buy Neumora Therapeutics stock.

Is Neumora Therapeutics profitable or losing money?

As of the last Neumora Therapeutics earnings report, Neumora Therapeutics is currently losing money. Neumora Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$252.09 million, a 8.06% decrease year over year.

What was NMRA's earnings growth in the past year?

As of Neumora Therapeutics's earnings date in Invalid Date, Neumora Therapeutics's earnings has grown year over year. NMRA earnings in the past year totalled -$252.09 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.